Akili Price to Book Ratio 2022-2023 | AKLI

Historical price to book ratio values for Akili (AKLI) over the last 10 years. The current price to book ratio for Akili as of May 09, 2024 is 0.59.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Akili Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-05-09 0.44 0.59
2023-12-31 0.49 $0.75 0.65
2023-09-30 0.55 $0.88 0.62
2023-06-30 1.11 $1.06 1.05
2023-03-31 1.60 $1.18 1.35
2022-12-31 1.12 $1.42 0.79
2022-09-30 2.26 $1.59 1.42
2022-06-30 9.89 $-2.15 -4.61
2022-03-31 9.89 $-1.84 -5.37
2021-12-31 9.93 0.00
2021-09-30 9.95 $-0.92 -10.83
2021-06-30 10.11 $0.00 3261.29
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.035B $0.002B
Akili Interactive is a digital medicine company pioneering the development of cognitive treatments through game-changing technologies. The company's platform is powered by proprietary therapeutic engines designed to target cognitive impairment. Akili Interactive, formerly known as Roblox, is based in BOSTON, Calif.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.763B 20.73
Inspire Medical Systems (INSP) United States $5.181B 0.00
Axonics (AXNX) United States $3.439B 0.00
10x Genomics (TXG) United States $3.145B 0.00
IRhythm Technologies (IRTC) United States $3.107B 0.00
Azenta (AZTA) United States $2.928B 159.12
Olink Holding AB (publ) (OLK) Sweden $2.910B 0.00
Enovis (ENOV) United States $2.800B 20.75
Hims & Hers Health (HIMS) United States $2.768B 0.00
Privia Health (PRVA) United States $2.139B 120.20
Schrodinger (SDGR) United States $1.673B 0.00
Omnicell (OMCL) United States $1.389B 48.02
Phreesia (PHR) United States $1.238B 0.00
Standard BioTools (LAB) United States $0.699B 0.00
Fulgent Genetics (FLGT) United States $0.652B 0.00
Definitive Healthcare (DH) United States $0.610B 0.00
Talkspace (TALK) United States $0.483B 0.00
Clover Health Investments (CLOV) United States $0.428B 0.00
Health Catalyst (HCAT) United States $0.394B 0.00
Pulmonx (LUNG) United States $0.340B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.314B 0.00
P3 Health Partners (PIII) United States $0.231B 0.00
Butterfly Network (BFLY) United States $0.205B 0.00
Outset Medical (OM) United States $0.169B 0.00
American Well (AMWL) United States $0.152B 0.00
TruBridge (TBRG) United States $0.123B 5.26
Augmedix (AUGX) United States $0.122B 0.00
MSP Recovery (LIFW) United States $0.120B 0.00
111 (YI) China $0.095B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.073B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.060B 0.00
Zepp Health (ZEPP) China $0.054B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
EUDA Health Holdings (EUDA) Singapore $0.046B 0.00
Movano (MOVE) United States $0.039B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
CareCloud (CCLD) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Biotricity (BTCY) United States $0.011B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00